Literature DB >> 28422703

Differential hemoglobin A sequestration between hemodialysis modalities.

Uzma Naseeb1, Shamshad Zarina1, Theres Jägerbrink1, Jawed Shafqat1, Hans Jörnvall1, Jonas Axelsson1.   

Abstract

This report evaluates plasma protein patterns, dialysates and protein analysis of used dialysis membranes from the same patient under hemodialysis in three separate modalities, using high-flux membranes in concentration-driven transport (HD), convection-driven hemofiltration (HF) and combined hemodialfiltration (HDF). The plasma protein changes induced by each of the three dialysis modalities showed small differences in proteins identified towards our previous plasma analyses of chronic kidney disease (CKD) patients. The used dialysate peptide concentrations likewise exhibited small differences among the modalities and varied in the same relative order as the plasma changes, with protein losses in the order HD>HDF>HF. The membrane protein deposits allowed quantification of the relative Hb removal ratios as ~1.7 for HD and ~1.2 for HDF vs. ~1.0 for HF. Hence, plasma protein alterations, dialysate peptide contents and membrane Hb deposits all identify HD as the modality with the most extensive filtration results and exemplifies the accessibility of protein analysis of used membrane filters for evaluation of dialysis efficiencies.

Entities:  

Keywords:  hemodialysis modalities; hemoglobin; plasma; protein

Mesh:

Substances:

Year:  2017        PMID: 28422703     DOI: 10.1515/bmc-2017-0006

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  2 in total

Review 1.  Examining hemodialyzer membrane performance using proteomic technologies.

Authors:  Mario Bonomini; Luisa Pieroni; Lorenzo Di Liberato; Vittorio Sirolli; Andrea Urbani
Journal:  Ther Clin Risk Manag       Date:  2017-12-18       Impact factor: 2.423

2.  Assessment of removal and adsorption enhancement of high-flux hemodialyzers in convective therapies by a novel in vitro uremic matrix.

Authors:  Miquel Gomez; Elisenda Bañon-Maneus; Marta Arias-Guillén; Francisco Maduell
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.